Upgrades

Strong operational performance had a positive surprise with revenue growth of 7% to Rs 9,150 crore versus our expectations of Rs 8,920 crore, margins too shone, with OPM improving by 407 bps.

Marico’s Q4FY25 numbers were a mixed bag, led by sequential improvement in volume growth in the domestic business and revenue beating estimates, while OPM fell y-o-y and missed estimates.

In Q4FY25, SBI Life reported a decline in both net premium and total income. Despite this, the company remains strategically focused on long-term growth through strengthening its agency and bancassurance channels, improving the product mix with increased emphasis on non-ULIP and protection products, advancing digital capabilities, and expanding its presence in underserved regions....

*over or under performance to benchmark index TIIs revenue stream with growth in the core sector, and industrial segments like railways & power continue to support long-term revenue visibility. The company is exploring significant diversification beyond the automotive sector due to cyclicality in the industry, especially considering the weak performance in the Passenger Vehicle (PV) and Heavy Commercial Vehicle (HCV) segments. Further, recovery in EV expansion builds stability for the long term....

overall EBITDA/kg to inch upwards to Rs40/kg by FY26. realization and stable volume growth (7.3%). MTEP expects double-digit by superior EBITDA/kg of Rs100/ Rs70 for Pharma/Food business. MTEP has given positive outlook in the near term led by 1) Growing traction in...

Indonesia reports 2% SSG, geopolitical impact eases off significantly by focus on value proposition and healthy growth in store traffic with ADS of 108k and Adj loss at Rs254mn vs est of Rs270. Indonesia business reported 9.7% decline in sales (BK-Indonesia SSG came at 2%), however green shoots in demand recovery are visible with stabilizing geopolitical scenario and closure of non-performing stores. RBA's India strategy is centered around 1) Value...

Management guided for 20%+ revenue growth with PBT margins of 5.25%5.5% on a standalone basis along with order intake of Rs260-280bn in FY26. We revise our FY26/FY27E EPS estimate by 1.8%/-3.6%, due to delayed collection in the Water business impacting the revenue. Kalpataru Projects International (KPIL) reported a 20.5% YoY increase in standalone revenue, with EBITDA margin improving by 66 bps to 8.4%. Growth was driven by strong execution across a robust order book, though delays in payment collections...

Service EBITDA margin of PTL business zooms to 10.8% (2.2% in 4QFY24). our service EBITDA margin assumptions for PTL division amid stellar performance in 4QFY25. DELHIVER reported strong set of results with operating margin of 5.4% (PLe 3.7%; CE 3.4%) as service EBITDA margin of PTL business skyrocketed to 10.8% led by improvement in yield, fleet utilization and volumes. While growth challenges in B2C parcel division continue (flat volumes with 170bps reduction in service EBITDA margin), we believe acquisition of Ecom express will not only drive yields but also improve margins as operating leverage benefits would come into play with a wider network coverage. We...

Divi's Laboratories (DIVI) Q4FY25 EBITDA beat our estimates led by higher gross margin (62%; up 200 bps QoQ). We expect GMs to sustain, led by better product mix and stable raw material prices. Mgmt. suggested that moderation of raw material prices, increasing RFP's and commencement of some CDMO and contrast media contracts, will continue to aid revenues and margins. Our FY26E/FY27E EPS estimates broadly remain unchanged. We expect 22% EBITDA CAGR and 15% PAT CAGR over FY25-27E. At CMP, stock is trading at...